manidipine has been researched along with Hypertension, Malignant in 2 studies
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohta, Y | 1 |
| Chikugo, T | 1 |
| Suzuki, T | 1 |
| Chichibu, S | 1 |
| Okamura, M | 1 |
| Konishi, Y | 1 |
| Nishimura, M | 1 |
| Negoro, N | 1 |
| Umetani, N | 1 |
| Inoue, T | 1 |
| Kanayama, Y | 1 |
| Takeda, T | 1 |
2 other studies available for manidipine and Hypertension, Malignant
| Article | Year |
|---|---|
Electroencephalographic evaluation of the therapeutic efficiency of antihypertensive agents on M-SHRSP.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Wei | 1995 |
Platelet-derived growth factor gene expression in the kidney of malignant hypertension.
Topics: Animals; Base Sequence; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, | 1992 |